Does REGORAFENIB Cause Metastases to lung? 304 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 304 reports of Metastases to lung have been filed in association with REGORAFENIB (Stivarga). This represents 3.2% of all adverse event reports for REGORAFENIB.
304
Reports of Metastases to lung with REGORAFENIB
3.2%
of all REGORAFENIB reports
86
Deaths
67
Hospitalizations
How Dangerous Is Metastases to lung From REGORAFENIB?
Of the 304 reports, 86 (28.3%) resulted in death, 67 (22.0%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Metastases to lung Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 304 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Metastases to lung?
LETROZOLE (703)
RIBOCICLIB (649)
CAPECITABINE (616)
BEVACIZUMAB (578)
PACLITAXEL (563)
FULVESTRANT (560)
EVEROLIMUS (522)
TRASTUZUMAB (458)
DOCETAXEL (415)
FLUOROURACIL (375)
Which REGORAFENIB Alternatives Have Lower Metastases to lung Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR